Due to the concern about the growing prevalence of unapproved GLP-1s on the market, the FDA issued warning letters to the following companies in December: The FDA warned the companies about potential violations of the Federal Food, Drug, and Cosmetic Act (FD&C Act), even with the companies claiming some of their GLP-1 products were currently for research purposes only
If individuals experience feelings of depression, including hopelessness, guilt, numbness, grief, and loneliness, B12 shots can offer relief
You are gonna lose muscle if you don't do something about it, but you can do something about it, that is the beautiful thing
Folic acid supplementation improves cognitive function by reducing the levels of peripheral inflammatory cytokines in elderly Chinese subjects with MCI
semaglutide in obesity An analysis in Diabetes, Obesity and Metabolism suggest that the cost per 1% of body weight reduction is lower for tirzepatide than semaglutide
Others, like Louisiana's, don't cover Wegovy at all but cover an old weight loss drug, Orlistat, which is considered less effective